Definitive Healthcare Corp Net Income
| DH Stock | USD 2.05 0.12 5.53% |
As of the 4th of February, Definitive Healthcare shows the Mean Deviation of 2.65, variance of 16.39, and Standard Deviation of 4.05. Definitive Healthcare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Definitive Healthcare Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.8861 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -6.9 M | -7.3 M | |
| Net Loss | -532.3 M | -505.7 M | |
| Net Loss | -532.3 M | -505.7 M | |
| Net Loss | (4.07) | (3.87) | |
| Net Income Per E B T | 0.75 | 0.64 |
Definitive | Net Income | Build AI portfolio with Definitive Stock |
The Net Income trend for Definitive Healthcare Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Definitive Healthcare is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Definitive Healthcare's Net Income Growth Pattern
Below is the plot of the Net Income of Definitive Healthcare Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Definitive Healthcare financial statement analysis. It represents the amount of money remaining after all of Definitive Healthcare Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Definitive Healthcare's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definitive Healthcare's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (591.45 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Definitive Net Income Regression Statistics
| Arithmetic Mean | (106,838,389) | |
| Coefficient Of Variation | (128.03) | |
| Mean Deviation | 107,434,243 | |
| Median | (36,398,000) | |
| Standard Deviation | 136,783,836 | |
| Sample Variance | 18709.8T | |
| Range | 405.9M | |
| R-Value | (0.72) | |
| Mean Square Error | 9668.8T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (19,448,557) | |
| Total Sum of Squares | 299357.1T |
Definitive Net Income History
Other Fundumenentals of Definitive Healthcare
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Definitive Healthcare Net Income component correlations
Definitive Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Definitive Healthcare is extremely important. It helps to project a fair market value of Definitive Stock properly, considering its historical fundamentals such as Net Income. Since Definitive Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Definitive Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Definitive Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Technology market expansion? Will Definitive introduce new products? Factors like these will boost the valuation of Definitive Healthcare. Projected growth potential of Definitive fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.72) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Definitive Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Definitive Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Definitive Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Definitive Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Definitive Healthcare's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Definitive Healthcare.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Definitive Healthcare on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Definitive Healthcare Corp or generate 0.0% return on investment in Definitive Healthcare over 90 days. Definitive Healthcare is related to or competes with National Research, TruBridge, Spok Holdings, Kindly MD, Sophia Genetics, Kyverna Therapeutics, and Editas Medicine. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United S... More
Definitive Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Definitive Healthcare's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Definitive Healthcare Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 30.23 | |||
| Value At Risk | (5.53) | |||
| Potential Upside | 4.85 |
Definitive Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Definitive Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Definitive Healthcare's standard deviation. In reality, there are many statistical measures that can use Definitive Healthcare historical prices to predict the future Definitive Healthcare's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | (0.35) |
Definitive Healthcare February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.34) | |||
| Mean Deviation | 2.65 | |||
| Coefficient Of Variation | (1,253) | |||
| Standard Deviation | 4.05 | |||
| Variance | 16.39 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | (0.35) | |||
| Maximum Drawdown | 30.23 | |||
| Value At Risk | (5.53) | |||
| Potential Upside | 4.85 | |||
| Skewness | (0.28) | |||
| Kurtosis | 5.44 |
Definitive Healthcare Backtested Returns
Definitive Healthcare secures Sharpe Ratio (or Efficiency) of -0.0809, which denotes the company had a -0.0809 % return per unit of risk over the last 3 months. Definitive Healthcare Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Definitive Healthcare's Mean Deviation of 2.65, variance of 16.39, and Standard Deviation of 4.05 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.95, which means possible diversification benefits within a given portfolio. Definitive Healthcare returns are very sensitive to returns on the market. As the market goes up or down, Definitive Healthcare is expected to follow. At this point, Definitive Healthcare has a negative expected return of -0.33%. Please make sure to confirm Definitive Healthcare's skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if Definitive Healthcare performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.59 |
Modest predictability
Definitive Healthcare Corp has modest predictability. Overlapping area represents the amount of predictability between Definitive Healthcare time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Definitive Healthcare price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Definitive Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Definitive Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Definitive Healthcare Corp reported net income of (591.45 Million). This is 273.3% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is significantly higher than that of the company.
Definitive Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Definitive Healthcare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Definitive Healthcare could also be used in its relative valuation, which is a method of valuing Definitive Healthcare by comparing valuation metrics of similar companies.Definitive Healthcare is currently under evaluation in net income category among its peers.
Definitive Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Definitive Healthcare from analyzing Definitive Healthcare's financial statements. These drivers represent accounts that assess Definitive Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Definitive Healthcare's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 2.7B | 1.1B | 1.1B | 479.4M | 551.3M | 523.7M | |
| Enterprise Value | 2.5B | 1.2B | 1.3B | 627.1M | 721.2M | 685.1M |
Definitive Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Definitive Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Definitive Healthcare's managers, analysts, and investors.Environmental | Governance | Social |
Definitive Healthcare Institutional Holders
Institutional Holdings refers to the ownership stake in Definitive Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Definitive Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Definitive Healthcare's value.| Shares | Bank Of America Corp | 2025-06-30 | 769.4 K | New York State Common Retirement Fund | 2025-06-30 | 766.4 K | Renaissance Technologies Corp | 2025-06-30 | 703.4 K | Aqr Capital Management Llc | 2025-06-30 | 665 K | Ubs Group Ag | 2025-06-30 | 476.3 K | Charles Schwab Investment Management Inc | 2025-06-30 | 402.1 K | Connor Clark & Lunn Inv Mgmt Ltd | 2025-06-30 | 361 K | Northern Trust Corp | 2025-06-30 | 345.5 K | Citadel Advisors Llc | 2025-06-30 | 333.1 K | Advent International Lp | 2025-06-30 | 62.5 M | Goldman Sachs Group Inc | 2025-06-30 | 8.7 M |
Definitive Fundamentals
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.0087 | ||||
| Profit Margin | (0.78) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 231.21 M | ||||
| Shares Outstanding | 103.3 M | ||||
| Shares Owned By Insiders | 8.65 % | ||||
| Shares Owned By Institutions | 93.96 % | ||||
| Number Of Shares Shorted | 2.29 M | ||||
| Price To Book | 0.79 X | ||||
| Price To Sales | 0.93 X | ||||
| Revenue | 252.2 M | ||||
| Gross Profit | 203.3 M | ||||
| EBITDA | (567.24 M) | ||||
| Net Income | (591.45 M) | ||||
| Cash And Equivalents | 347.87 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 253.11 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 3.32 X | ||||
| Book Value Per Share | 2.77 X | ||||
| Cash Flow From Operations | 58.2 M | ||||
| Short Ratio | 3.76 X | ||||
| Earnings Per Share | (1.72) X | ||||
| Price To Earnings To Growth | 1.03 X | ||||
| Target Price | 3.91 | ||||
| Number Of Employees | 782 | ||||
| Beta | 1.59 | ||||
| Market Capitalization | 225.87 M | ||||
| Total Asset | 1.09 B | ||||
| Retained Earnings | (640.57 M) | ||||
| Working Capital | 209.01 M | ||||
| Net Asset | 1.09 B |
About Definitive Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Definitive Healthcare Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Definitive Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Definitive Healthcare Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is there potential for Health Care Technology market expansion? Will Definitive introduce new products? Factors like these will boost the valuation of Definitive Healthcare. Projected growth potential of Definitive fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.72) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Definitive Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Definitive Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Definitive Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.